This miR is released by exosomes and promotes tumor proliferation and viability by targeting KLF9 and, thus, sustains progression of Non-Small Cell Lung Cancer (NSCLC) [58]. The gene discussed is KLF9; the disease is non-small cell lung carcinoma.